Inhaled SalmeterolA Review of its Efficacy in Chronic Obstructive Pulmonary Disease

被引:0
作者
Blair Jarvis
Anthony Markham
机构
[1] Adis International Limited,
来源
Drugs & Aging | 2001年 / 18卷
关键词
Chronic Obstructive Pulmonary Disease; Salbutamol; Salmeterol; Formoterol; Chronic Obstructive Pulmonary Disease Exacerbation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:441 / 472
页数:31
相关论文
共 238 条
  • [1] Fiel SB(1996)Chronic obstructive pulmonary disease: mortality and mortality reduction Drugs 52 55-61
  • [2] Soriano JB(1997)BTS guidelines for the management of chronic obstructive pulmonary disease Thorax 52 S1-S28
  • [3] Maier WC(2000)Recent trends in physician diagnosed COPD in women and men in the UK Thorax 55 789-94
  • [4] Egger P(1999)The annual cost of chronic obstructive pulmonary disease to the UK’s National Health Service Dis Manage Health Outcomes 5 93-100
  • [5] Guest JE(2000)Health care utilization in chronic obstructive pulmonary disease: a case-control study in a health maintenance organization Arch Intern Med 160 2653-8
  • [6] Mapel DW(1995)Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 152 S77-S120
  • [7] Hurley JS(2000)Pharmacoeconomic evaluation of COPD Chest 118 1278-85
  • [8] Frost FJ(2001)The costs of treating COPD in the United States Chest 119 344-52
  • [9] Celli BR(1998)Chronic obstructive pulmonary disease Lancet 352 467-73
  • [10] Snider GL(2000)Chronic obstructive pulmonary disease N Engl J Med 343 269-80